Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

340 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Establishment of histological criteria for high-risk node-negative breast carcinoma for a multi-institutional randomized clinical trial of adjuvant therapy. Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) Pathology Section.
Tsuda H, Akiyama F, Kurosumi M, Sakamoto G, Watanabe T. Tsuda H, et al. Among authors: akiyama f. Jpn J Clin Oncol. 1998 Aug;28(8):486-91. doi: 10.1093/jjco/28.8.486. Jpn J Clin Oncol. 1998. PMID: 9769782 Clinical Trial.
Evaluation of the interobserver agreement in the number of mitotic figures of breast carcinoma as simulation of quality monitoring in the Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) protocol.
Tsuda H, Akiyama F, Kurosumi M, Sakamoto G, Yamashiro K, Oyama T, Hasebe T, Kameyama K, Hasegawa T, Umemura S, Honma K, Ozawa T, Sasaki K, Morino H, Ohsumi S. Tsuda H, et al. Among authors: akiyama f. Jpn J Cancer Res. 2000 Apr;91(4):451-7. doi: 10.1111/j.1349-7006.2000.tb00966.x. Jpn J Cancer Res. 2000. PMID: 10804295 Free PMC article.
Histopathological criteria for assessment of therapeutic response in breast cancer.
Kurosumi M, Akiyama F, Iwase T, Motomura K, Okazaki M, Tsuda H; Commitee for Production of Histopathological Criteria, Japanese Breast Cancer Society. Kurosumi M, et al. Among authors: akiyama f. Breast Cancer. 2001;8(1):1-2. doi: 10.1007/BF02967471. Breast Cancer. 2001. PMID: 11180759 No abstract available.
Detection of HER-2/neu (c-erb B-2) DNA amplification in primary breast carcinoma. Interobserver reproducibility and correlation with immunohistochemical HER-2 overexpression.
Tsuda H, Akiyama F, Terasaki H, Hasegawa T, Kurosumi M, Shimadzu M, Yamamori S, Sakamoto G. Tsuda H, et al. Among authors: akiyama f. Cancer. 2001 Dec 15;92(12):2965-74. doi: 10.1002/1097-0142(20011215)92:12<2965::aid-cncr10156>3.0.co;2-a. Cancer. 2001. PMID: 11753973 Clinical Trial.
340 results